Cuffe Michael S. (CIK 1632835) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-12). Recent activity: Buy HCA (9,628 shares), Sell HCA (3,501 shares), Sell HCA (1,500 shares), Sell HCA (4,050 shares), Buy HCA (10,920 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-12 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Buy | 9,628 | $0 |
| 2026-02-12 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Sell | 3,501 | $1.8M |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Sell | 1,500 | $747,135 |
| 2026-02-05 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Sell | 4,050 | $0 |
| 2025-09-08 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Buy | 10,920 | $1.9M |
| 2025-09-08 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Sell | 7,084 | $2.9M |
| 2025-09-08 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Sell | 3,836 | $1.6M |
| 2025-02-18 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Buy | 2,330 | $0 |
| 2025-02-18 | HCA Healthcare, Inc. (HCA) | EVP and Chief Clinical Officer | Sell | 583 | $187,679 |
Source: SEC Form 4 filings · as of 2026-02-12